Detalles de la búsqueda
1.
Tool evaluation for the detection of variably sized indels from next generation whole genome and targeted sequencing data.
PLoS Comput Biol
; 18(2): e1009269, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176018
2.
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group.
Eur J Haematol
; 109(3): 257-270, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35634931
3.
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.
Br J Haematol
; 190(2): 198-208, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32175599
4.
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Lancet Oncol
; 19(6): 747-757, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735299
5.
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
Blood
; 118(12): 3228-35, 2011 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21685374
6.
Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy.
Blood
; 116(5): 772-82, 2010 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20413659
7.
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.
Blood
; 116(22): e111-7, 2010 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20720184
8.
Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers.
Virchows Arch
; 480(4): 807-817, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35237889
9.
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.
Leukemia
; 36(7): 1834-1842, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35614319
10.
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
Blood
; 113(19): 4497-504, 2009 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-19264678
11.
Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myeloma.
Eur J Haematol
; 85(5): 416-23, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20722702
12.
Association of injury severity, MRI-results and ApoE genotype with 1-year outcome in mainly mild TBI: a preliminary study.
Brain Inj
; 23(5): 396-402, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19408164
13.
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
Cancers (Basel)
; 11(11)2019 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31717978
14.
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.
Br J Haematol
; 160(4): 561-4, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23206270
15.
Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia.
Haematologica
; 93(2): 178-85, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18223279
16.
Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
Eur J Haematol
; 80(3): 201-7, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18081724
17.
Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR.
Eur J Haematol
; 81(2): 100-6, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18410542
18.
Outcome of traumatic brain injury after three decades--relationship to ApoE genotype.
J Neurotrauma
; 23(11): 1600-8, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17115907
19.
ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status.
Eur J Haematol
; 85(4): 361-2, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20546020
20.
Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile.
PLoS One
; 6(8): e23022, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21857985